Sitemap
Medical & Environmental Radiation and Complications of Cancer Therapy
- Treatment of Hemorrhagic Radiation Proctitis (Radiation Proctopathy) with an Argon Plasma Coagulation (APC)
- Radioactive Decay
- Radiation Dose Equivalent
- Effective Half-Life for a Radionuclide
- Effective Dose Equivalent (EDE)
- Preliminary Evaluation of Clinical Radiation Injury (Thoma-Wald Diagnostic Classification System)
- Dosing of Potassium Iodide as a Thyroid Blocking Agent in a Radiation Emergency
- Radiation Injury Severity Classification (RISC) System
- Equation of Azizova et al for Correlating the Absolute Lymphocyte Count on Day 3 After an Exposure and the Radiation Dose
- Equation of Azizova et al for Correlating the Absolute Neutrophil Count Within a Few Hours After an Exposure and the Radiation Dose
- Equation of Azizova et al for Correlating the Onset of Vomiting After an Exposure and the Radiation Dose
- Symptom Profile in Patients Receiving Radiation Therapy
- Common Toxicity Criteria (CTC) for Pain Associated with Cancer Therapy
- Morrow Assessment of Nausea and Emesis (MANE) Associated with Chemotherapy
- Anticipatory Nausea Index of Nerenz et al for Cancer Chemotherapy
- Emetic Effect of Chemotherapeutic Agents
- Common Toxicity Criteria (CTC) for Constitutional Symptoms Associated with Cancer Therapy
- The TAME (T-A-M End-Result) System for Reporting Adverse Events Associated with Cancer Therapy
- Impact of Autoimmune Disease on the Severity of Radiation Toxicity
- Model of Hurria et al for Predicting Chemotherapy-Related Toxicity in an Older Adult with Cancer
- Emetic Effect of Radiation Therapy
- Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score of Extermann et al
- Tool of Dranitsaris et al for Predicting Acute Chemotherapy-Induced Nausea and Vomiting (CINV)
- Tool of Petrella et al for Predicting Delayed Chemotherapy-Induced Nausea and Vomiting (CINV)
- Predictive Model of Mac Manus et al for Neutropenia and Thrombocytopenia After Radiation Therapy
- RTOG/EORTC Criteria for Hematologic Complications to Irradiation
- SOMA-LENT Scoring of Hematologic Complications to Cancer Therapy
- WHO Criteria for Acute and Subacute Hematologic Toxic Effects of Cancer Therapy in Adults
- Common Toxicity Criteria (CTC) for Coagulation Complications Associated with Cancer Therapy
- Common Toxicity Criteria (CTC) for Infection or Febrile Neutropenia Associated with Cancer Therapy
- Common Toxicity Criteria (CTC) for Hemorrhage Associated with Cancer Therapy
- Common Toxicity Criteria (CTC) for Allergic and Immunologic Reactions Associated with Cancer Therapy
- Scale of Rebulla et al for Bleeding Following Therapy for Acute Leukemia
- Score of Nevo et al for Bleeding Following Bone Marrow Transplantation
- Common Toxicity Criteria (CTC) for Hematology Complications Associated with Cancer Therapy
- Hemolytic Uremic Syndrome Secondary to Chemotherapy
- Hemolytic Anemia Associated with Carmustine (BCNU) Chemotherapy
- Risk Model of Juan et al for Predicting Severe Anemia After Chemotherapy for a Non-Hematologic Malignancy
- Risk Factors of Lyman et al for Febrile Neutropenia Following Therapy for Aggressive Non-Hodgkin's Lymphoma
- Risk Factors of Blay et al for Predicting Febrile Neutropenia Following Chemotherapy
- Risk Score of Dranitsaris et al for Predicting Chemotherapy-Induced Anemia in a Woman with for Breast Cancer
- Tool of Vincent et al for Predicting Chemotherapy-Induced Anemia in a Patient with Advanced Nonsmall Cell Lung Cancer
- Risk Factors of Webert et al for Bleeding in a Patient with Acute Myeloid Leukemia and Thrombocytopenia
- Retinoic Acid Syndrome in Patients with Acute Promyelocytic Leukemia
- Anemia Due to Erythropoietin Deficiency During Cisplatin Therapy
- Risk Factors for Bleeding in a Patient Receiving Dasatinib Therapy for Chronic Myelogenous Leukemia (CML)
- Thrombotic Thrombocytopenic Purpura (TTP) or Microangiopathic Hemolytic Anemia Associated with Bevacizumab (Avastin, Anti-VEGF) Therapy
- Bleeding Associated with Bevacizumab Therapy
- Scoring System of Walsh et al for Oral Mucositis in Patients Having a Bone Marrow Transplantation
- Oral Mucositis Grading Score of Toth et al
- Patient Questionnaire of Rothwell and Spektor for Symptoms of Oral Mucositis
- RTOG/EORTC Criteria for Mucous Membrane Complications to Irradiation
- RTOG/EORTC Criteria for Radiation Complications in Salivary Glands
- Oral Mucositis Index (OMI) of Schubert et al
- Oral Mucositis Assessment Scale (OMAS) of Sonis et al
- Oral Mucositis Evaluation of Epstein et al in a Patient Receiving Radiation Therapy for a Cancer of the Head and Neck
- SOMA-LENT Scoring of Salivary Gland Complications Following Cancer Therapy
- SOMA-LENT Scoring of Oral and Pharyngeal Complications Following Cancer Therapy
- SOMA-LENT Scoring of Dental Complications Following Cancer Therapy
- SOMA-LENT Scoring of Mandibular Complications Following Cancer Therapy
- Modified Patient Evaluation Form of Rothwell and Spektor for Oral Mucositis
- Radiation Mucositis Score of Spijkervet et al
- Salivary Gland Toxicity Associated with I-131 Therapy
- Risk Factors of Holtta et al for Agenesis and Microdontia of Permanent Teeth in Children Undergoing Stem Cell Transplantation
- Criteria of Annane et al for Severe Mandibular Osteoradionecrosis
- Risk Factors for Mandibular Osteoradionecrosis
- Criteria for Recovery from Mandibular Osteoradionecrosis
- Dental Disturbance Classification and Severity Rating Scale of Sonis et al Following Cranial Radiation Therapy in Pediatric Acute Lymphoblastic Leukemia
- Predictors of Robien et al for Oral Mucositis in a Patient with CML Undergoing Hematopoietic Cell Transplantation
- Oral Evaluation and Mucositis Grading of Seto et al in a Patient Following Bone Marrow Transplantation
- Clinical Features of Dirix et al for Radiation-Induced Xerostomia in a Patient with Cancer of the Head and Neck
- Risk Factors of Rask et al for Oral Mucositis in a Child Treated with High-Dose Methotrexate
- Risk Factors of Smith et al for Aspiration Following Free Flap Reconstruction Following an Oral Cavity or Oropharyngeal Tumor Resection
- Classification of Yoshioka et al for Tongue Hemiatrophy Following Brachytherapy for Tongue Cancer
- Risk Factors of Kaste et al for Dental Abnormalities Following Radiation and Chemotherapy for a Pediatric Cancer
- Risk Factors of Suarez-Cunqueiro et al for Speech and Swallowing Difficulties Following Therapy of an Oral or Oropharyngeal Cancer
- Dental and Salivary Gland Complications of Cyclophosphamide Therapy in Pediatric Patients with Cancer
- Interventions to Help Manage a Patient with Oral Mucositis
- Risk Factors of Grazziutti et al for Severe Oral Mucositis in a Patient Undergong Melphalan-Based Autologous Stem Cell Transplant for Myeloma
- Grading Systems of Eisbruch et al for Radiotherapy-Induced Xerostomia
- RTOG/EORTC Criteria for Lung Complications to Irradiation
- RTOG/EORTC Criteria for Laryngeal Complications to Irradiation
- SOMA-LENT Scoring of Laryngeal Complications Following Cancer Therapy
- SOMA-LENT Scoring of Pulmonary Complications Following Cancer Therapy
- Common Toxicity Criteria (CTC) for Pulmonary Complications Associated with Cancer Therapy
- Screening Questionnaire of van Gogh et al for Voice Impairment After Treatment of Early Glottic Cancer
- Definition of the Idiopathic Pneumonia Syndrome (IPS) Following Bone Marrow or Allogeneic Stem Cell Transplantation
- Risk Factors for Idiopathic Pneumonia Syndrome Following Bone Marrow or Allogeneic Stem Cell Transplantation
- Clinical Features of Diffuse Alveolar Hemorrhage (DAH) Following Bone Marrow or Allogeneic Stem Cell Transplantation
- Clinical Features of Periengraftment Respiratory Distress Syndrome (PERDS) Following Stem Cell Transplantation
- Risk Factors of Wall and Schnapp for Radiation-Induced Lung Injury
- Clinical Features of Wall and Schnapp for Radiation Pneumonitis
- Cytotoxic Lung Injury Associated with Bleomycin
- Cytotoxic Lung Injury Associated with Busulfan
- Risk Factors of Haugnes et al for Restrictive Lung Disease in a Long-Term Survivor of Testicular Cancer
- Risk Factors of Ando et al for Interstitial Lung Disease Following Therapy with Gefitinib in a Patient with Non-Small Cell Lung Cancer
- Risk Factors of Al Ameri et al for Acute Pulmonary Failure During Remission Induction Chemotherapy for Acute Myeloid Leukemia or High-Risk Myelodysplasia
- Pulmonary Arterial Hypertension Associated with Dasatinib (Sprycel) Therapy
- Equation and Nomogram of Bradley et al for Predicting Radiation Pneumonitis
- Risk Factors for Pulmonary Toxicity Associated with Erlotinib Therapy
- Risk Factors for Pulmonary Toxicity Associated with Gemcitabine Therapy
- Risk Factors for Pulmonary Toxicity Associated with Taxane Therapy
- RTOG/EORTC Criteria for Cardiac Complications from Irradiation
- SOMA-LENT Scoring of Vascular Complications Following Cancer Therapy
- SOMA-LENT Scoring of Cardiac Complications Following Cancer Therapy
- Common Toxicity Criteria (CTC) for Cardiac Arrhythmias Associated with Cancer Therapy
- Common Toxicity Criteria (CTC) for Lymphatic Complications Associated with Cancer Therapy
- Common Toxicity Criteria (CTC) for Cardiovascular Complications Associated with Cancer Therapy
- Delayed Radiation-Induced Changes in Arteries
- Venous Sclerosis Following Infusion of a Chemotherapeutic Agent
- Recommendations of Patel et al for Evaluating a Patient for Atherosclerotic Vascular Disease Following Moderate to High Dose Radiation Therapy
- Risk Factors of Hancock et al for Late Cardiac Mortality Following Mediastinal Irradiation for Hodgkin's Disease
- Arterial Thromboembolism Associated with Bevacizumab Therapy
- Risk Factors for Cardiotoxicity Following Doxorubicin Therapy
- Electron Microscopic Grading of Doxorubicin Cardiotoxicity
- Risk Factors of Armenian et al for Late Congestive Heart Failure Following a Hematopoietic Cell Transplant
- Heart Failure Associated with Sunitinib Malate Therapy
- Conversion Factors of Keefe et al for Comparing Cardiotoxicity of Various Anthracyclines
- Algorithm of Keefe for Monitoring a Patient Receiving an Anthracycline
- Risk Factors for Cardiomyopathy in a Patient with Down's Syndrome Following Anthracycline Chemotherapy
- Hypertension During Treatment with a Vascular Endothelial Growth Factor (VEGF) Signal Inhibitor
- Adjuvant Cardiac Review and Evaluation Committee (ACREC) Criteria for Symptomatic Heart Failure Associated with Adjuvant Chemotherapy
- Cardiac Toxicity and Heart Failure Associated with Bevacizumab Therapy
- Risk for Coronary Artery Stenosis Following Radiation Therapy for Breast Cancer
- Questionnaire for Bowel Symptoms After Radiation Therapy for Prostate Cancer
- RTOG/EORTC Criteria for Complications to Irradiation in the Pharynx and Esophagus
- RTOG/EORTC Criteria for Intestinal Complications from Irradiation
- Radiation Proctitis Symptom Scale of Kennedy et al
- SOMA-LENT Scoring of Gastric Complications to Cancer Therapy
- Risk Factors for Intestinal Injury Following Radiation Therapy
- SOMA-LENT Scoring of Esophageal Complications Following Cancer Therapy
- SOMA-LENT Scoring of Rectal Complications Following Cancer Therapy
- SOMA-LENT Scoring of Complications Involving the Small Intestine and Colon Following Cancer Therapy
- WHO Criteria for Acute and Subacute Gastrointestinal Toxic Effects of Cancer Therapy in Adults
- Esophageal Stricture Following Radiotherapy for Head and Neck Carcinoma
- Recommendations of Waddell et al for Prevention of Chronic Radiation Enteritis
- Common Toxicity Criteria (CTC) for Gastrointestinal Adverse Events Associated with Cancer Therapy
- Risk Factors of Maguire et al for Late Esophageal Toxicity After High Dose Conformal Radiation Therapy for Lung Carcinoma
- Daily Gut Score of Blijlevens et al for Gastrointestinal Toxicity Associated with Cancer Therapy
- Monitoring Serum Citrulline Concentrations as a Measure of Small Bowel Toxicity Secondary to Myeloablative Therapy
- Recommendations for Management of Chemotherapy-Induced Diarrhea in a Patient Receiving Irinotecan, Fluorouracil, and Leucovorin (IFL) Regimen
- Criteria for Complicated and Uncomplicated Chemotherapy-Induced Diarrhea
- Gastrointestinal Perforation Associated with Bevacizumab Therapy
- Hiccups Associated with Cancer Chemotherapy
- Risk Factors of Covens et al for a Patient with Radiation-Induced Bowel Injury Requiring Surgical Management
- Modified Radiation Therapy Oncology Group (RTOG) Rectal Toxicity Scale for Late Complications
- Risk Factors for Gastrointestinal Perforation in a Patient Being Treated with Erlotinib (Tarceva)
- Tracheoesophageal Fistula Associated with Chemoradiation and Bevacizumab Therapy for Lung Cancer
- Cord Colitis Syndrome of Herrera et al in a Patient Who Has Received a Stem Cell Transplant Using Cord Blood
- Risk Factors of Atsumi et al for Esophageal Stenosis Following Radiotherapy for Esophageal Cancer
- Score of Dranitsaris et al for Predicting Severe Diarrhea Following Chemotherapy for Colorectal Carcinoma
- RTOG/EORTC Criteria for Hepatic Complications from Irradiation
- SOMA-LENT Scoring of Hepatic Complications to Cancer Therapy
- Common Toxicity Criteria (CTC) for Hepatic Adverse Events Associated with Cancer Therapy
- Clinical Features of the Sinusoidal Obstruction Syndrome (SOS, Veno-Occlusive Disease)
- Risk Factors for the Sinusoidal Obstruction Syndrome (SOS, Veno-Occlusive Disease)
- Risk Factors for Portal Hypertension in a Child Receiving Radiation Therapy for a Wilms Tumor
- Secondary Sclerosing Cholangitis (SSC) Following Chemotherapy
- Questionnaire for Bladder Symptoms After Radiation Therapy for Prostate Cancer
- RTOG/EORTC Criteria for Urinary Bladder Complications to Irradiation
- RTOG/EORTC Criteria for Renal Complications from Irradiation
- WHO Criteria for Acute and Subacute Urinary Tract Toxic Effects from Cancer Therapy
- SOMA-LENT Scoring of Renal Complications to Cancer Therapy
- SOMA-LENT Scoring of Ureteral Complications Following Cancer Therapy
- SOMA-LENT Scoring of Urinary Bladder and Urethral Complications Following Cancer Therapy
- Common Toxicity Criteria (CTC) for Renal and Genitourinary Adverse Events Associated with Cancer Therapy
- Cyclophosphamide (Cytoxan) Cystitis
- Radiation Nephropathy
- Subjective Urinary Symptom Questionnaire of Colombo et al in a Patient Following Therapy for Cancer of the Urinary Bladder
- Risk Factors of Choi et al for Chronic Renal Disease in a Patient with an Hematopoietic Cell Transplant
- Grading System of Skinner et al for Ifosfamide Nephrotoxicity
- Urinary Symptom Flare Associated with Brachytherapy for Prostate Cancer
- Renal Salt Wasting and Hyponatremia Associated with Chemotherapy
- Questionnaire for Sexual Problems After Radiation Therapy for Prostate Cancer
- SOMA-LENT Scoring of Female Sexual Dysfunction As a Complication to Cancer Therapy
- SOMA-LENT Scoring of Male Sexual Dysfunction As a Complication to Cancer Therapy
- SOMA-LENT Scoring of Ovarian and Female Reproductive Complications Following Cancer Therapy
- SOMA-LENT Scoring of Vulvar Complications Following Cancer Therapy
- SOMA-LENT Scoring of Testicular Complications Following Cancer Therapy
- SOMA-LENT Scoring of Vaginal Complications Following Cancer Therapy
- SOMA-LENT Scoring of Complications Involving the Uterus and Cervix Following Cancer Therapy
- Common Toxicity Criteria (CTC) for Sexual and Reproductive Adverse Events Associated with Cancer Therapy
- Risk Factors of Huyghe et al for Infertility Following Therapy for a Testicular Cancer
- Factors of Meistrich et al Affecting the Reduction in Sperm Count for a Man Treated with Cyclophosphamide (Cytoxan)
- Risk Factors Associated with Premature Ovarian Failure in a Woman Being Treated for Cancer
- Risk Factors of Schover for Dyspareunia in a Woman Who Is Being Treated for Breast Cancer
- Ovarian and Laboratory Findings Associated with Premature Ovarian Failure in a Woman Being Treated for Cancer
- Relative Impact of Various Chemotherapy Drugs on Spermatogenesis
- Risk Factors of Meirow et al for Severe Menorrhagia in a Woman with Treatment-Induced Thrombocytopenia
- Penile Shortening Following Therapy for Prostate Cancer
- RTOG/EORTC Criteria for Skin Complications to Irradiation
- RTOG/EORTC Criteria for Late Subcutaneous Tissue Injury from Irradiation.
- Grades of Local Toxicity Associated with Hyperthermic Isolated Limb Perfusion
- SOMA-LENT Scoring of Skin and Subcutaneous Tissue Complications Following Cancer Therapy
- SOMA-LENT Scoring of Complications in the Female Breast Following Cancer Therapy
- Common Toxicity Criteria (CTC) for Dermatologic Adverse Events Associated with Cancer Therapy
- Risk of Severe Injury Following Extravasation of a Chemotherapeutic Agent
- Acral Erythema (Hand and Foot Syndrome, Palmar Plantar Erythrodysaesthesia Syndrome)
- Grading Recommendations of Spazzapan et al for Nail Toxicity Associated with Weekly Chemotherapeutic Regimens
- Cutaneous Adverse Reactions Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitors
- Surgical Wound Complications Following Chemoradiation to the Head and Neck
- Risk Factors of Beesley et al for Lower Extremity Lymphedema in a Woman Following Gynecological Cancer Therapy
- Effect of Bevacizumab on Wound Healing
- Risk Factors of Meek for Upper Extremity Lymphedema in a Woman Following Breast Cancer Therapy
- Therapy with Dexrazoxane Following Extravasation of an Anthracycline
- Loss of Fingerprints Following Hand and Foot Syndrome (Acral Erythema) in a Patient Treated with Capecitabine
- Risk of Hair Loss Associated with Various Chemotherapeutic Agents
- Risk Factors of Vowels et al for Alopecia with Poor Hair Regrowth After a Pediatric Bone Marrow Transplant (BMT)
- Benign Vascular (Lymphangiomatous) Proliferations of the Skin Following Radiation Therapy for Breast Cancer
- Minimizing the Burden of Chemotherapy-Associated Hair Loss on a Patient
- RTOG/EORTC Criteria for Orthopedic Complications from Irradiation
- Common Toxicity Criteria (CTC) for Musculoskeletal Adverse Events Associated with Cancer Therapy
- SOMA-LENT Scoring of Muscle and Soft Tissue Complications Following Cancer Therapy
- SOMA-LENT Scoring of Complications Involving Mature Bone Following Cancer Therapy
- SOMA-LENT Scoring of Complications Involving Growing Bone Following Cancer Therapy
- Algorithm of Lin et al for Prophylactic Nailing of the Femur in a Patient at Risk for Pathologic Fracture After Radiation Therapy for Soft Tissue Sarcoma in the Thigh
- Tumor Flare Syndrome Following Therapy in Patients with Metastatic Carcinoma to Bone, with Common Toxicity Criteria (CTC)
- Risk Factors of Strauss et al for Skeletal Complications Following Therapy for Pediatric Acute Lymphoblastic Leukemia (ALL)
- Therapy-Related Risk Factors of Mandel et al for Decreased Bone Mineral Density in Pediatric Acute Lymphoblastic Leukemia (ALL)
- Risk Factors of Baxter et al for Pelvic or Femoral Neck Fracture in a Woman After Pelvic Irradiation
- Fascial Edema Following Chemotherapy (Pseudoscleroderma)
- Nomogram of Gortzak et al for Predicting the Risk of Pathologic Fracture of the Femur Following Treatment of a Soft Tissue Sarcoma of the Thigh
- Paclitaxel-Associated Myalgias and Arthralgias
- SOMA-LENT Scoring of Peripheral Nerve Complications to Cancer Therapy
- SOMA-LENT Scoring of Spinal Cord Complications to Cancer Therapy
- SOMA-LENT Scoring of Complications Involving the Brain Following Cancer Therapy
- RTOG/EORTC Criteria for Central Nervous System Complications After Irradiation
- WHO Criteria for Acute and Subacute Neurotoxic Effects of Cancer Therapy in Adults
- Clinical Features of Neuropathy Following Vinca Alkaloid Therapy
- Common Toxicity Criteria (CTC) for Neurological Adverse Events Associated with Cancer Therapy
- Radiation-Induced Dementia in a Patient Treated for Brain Metastases
- Cognitive Impairment Associated with Chemotherapy (Chemo Fog, Chemo Brain)
- Oxaliplatin-Specific Neurotoxic Scale (OSNS) for Peripheral Neuropathy
- Ifosfamide Encephalopathy
- Paclitaxel-Associated Acute Pain Syndrome (P-APS)
- Radiation-Induced Brachial Plexopathy
- Radiation-Associated Myelopathy
- RTOG/EORTC Criteria for Ocular Complications to Irradiation
- RTOG/EORTC Criteria for Complications Affecting the Ear After Irradiation
- SOMA-LENT Scoring of Complications to the Ear Following Cancer Therapy
- SOMA-LENT Scoring of Complications to the Eye Following Cancer Therapy
- Common Toxicity Criteria (CTC) for Auditory or Hearing Adverse Events Associated with Cancer Therapy
- Common Toxicity Criteria (CTC) for Ocular and Visual Adverse Events Associated with Cancer Therapy
- Risk Factors for Radiation Papillopathy and Maculopathy Following Intraocular Irradiation for Choroidal Melanoma
- Risk Factors for Hearing Loss Associated with Platinum-Based Chemotherapy
- Risk Factors of Archer et al for Radiation Retinopathy
- Clinical Features of Radiation Retinopathy
- Clinical Features of Radiation Optic Neuropathy
- Classification of Brock et al for Grading High-Frequency Hearing Loss in a Child Treated with Cisplatin
- Prognostic Factors of Demirci et al Affecting Visual Acuity in a Patient Undergoing Chemoreduction for Retinoblastoma
- Ocular Complications Following Therapy with Erlotinib (Tarceva)
- Risk Factors of Frisk et al for Cataracts Following a Bone Marrow Transplant
- SOMA-LENT Scoring of Thyroid Gland Complications to Cancer Therapy
- SOMA-LENT Scoring of Hypothalamic-Pituitary-Adrenal Complications of Cancer Therapy
- SOMA-LENT Scoring of Hypothalamic-Pituitary-Gonadal Complications in a Woman Following Cancer Therapy
- SOMA-LENT Scoring of Hypothalamic-Pituitary-Gonadal Complications in a Male Following Cancer Therapy
- Common Toxicity Criteria (CTC) for Endocrine Complications Associated with Cancer Therapy
- Common Toxicity Criteria (CTC) for Metabolic and Laboratory Complications Associated with Cancer Therapy
- Hyperammonemia Following Cytoreductive Chemotherapy
- Risk Factors of Metzger et al for Hypothyroidism Following Neck Irradiation of a Pediatric Patient for Hodgkin's Disease
- Risk Factors of Vogelius et al for Radiation-Induced Hypothyroidism
- Hyperparathyroidism Secondary to Sunitinib Therapy
- Criteria for Post-Irradiation Bone Sarcoma
- Risk of Lung Cancer Following Therapy for Hodgkin's Disease
- Therapy-Related Acute Myeloid Leukemia
- Risk Factors of Le Deley et al for Acute Leukemia in Children Treated for a Solid Tumor
- Risk Factors of Kalaycio et al for Secondary Myelodysplasia and Acute Myeloid Leukemia (AML) in a Patient Undergoing Autologous Stem Cell Transplantation for Malignant Lymphoma
- Angiosarcoma or Lymphangiosarcoma Arising in a Lymphedematous Extremity (Stewart-Treves Syndrome)
- Model of Le Deley et al for Predicting Acute Myeloid Leukemia or Myelodysplasia in a Woman Treated for Breast Cancer
- Risk Factors of Meadows et al for Secondary Malignant Neoplasm (SMN) in a Child with a Malignancy
- Risk Factors of Umansky et al for Radiation-Induced Meningiomas
- Risk Factors of Boukheris et al for a Radiation-Induced Salivary Gland Carcinoma in a Patient with Hodgkin's Lymphoma
- Alkylator Score of Tucker et al and Leukemia in Childhood Cancer Survivors
- Risk Factors of Bjorkholm et al for Development of Myelodysplasia or Acute Myeloid Leukemia Following Therapy of a Myeloproliferative Disorder
- Carcinomas of the Kidney and Urinary Tract in Patients Exposed to Radiation Events
- Indications for Postoperative Radiotherapy in Patients with Cancers of the Head and Neck
- Indications for External Radiation Therapy in Patients with Thyroid Cancer
- Indications of Clayman et al for Postoperative Radiation Therapy in a Patient with a Squamous Cell Carcinoma of the Skin
- Criteria of Suh for Selecting Radiotherapy to Treat a Brain Metastases
- Stereotactic Body Radiation Therapy (SBRT) for Inoperable Early Stage Non-Small Cell Lung Cancer
- Indications for Ablative Therapy with Iodine-131 in Patients with Thyroid Carcinoma
- Indications and Contraindications for Radionuclide Therapy for Pain Palliation in Bone Metastases
- Pain Score and Net Pain Relief Following Irradiation for the Palliation of Multiple Bone Metastases from Solid Tumors
- Assessing Effectiveness of Strontium-89 Chloride for Pain Palliation in Bone Metastases
- Pain Response Criteria of Chow et al for Palliative Radiotherapy of Bone Metastases
- Risk Factors for Adverse Reactions to Contrast Material
- Risk Factors for Nonionic Contrast Material-Induced Venous Thrombosis
- Risk Factors for Radiocontrast-Induced Acute Renal Injury
- Calculation of the Maximal Amount of Contrast Material That Can Be Used Without Deterioration of Renal Function
- Indications for Use of Low-Osmolality Contrast Materials
- Risk Equation of Mueller et al for Contrast-Associated Nephropathy in Patients Undergoing Coronary Angiography
- Complications of Using Radiocontrast Material in a Patients with Eisenmenger's Syndrome
- Salivary Gland Enlargement After Use of Iodide-Based Contrast Material (Iodide Mumps)
- Risk Score of Mehran et al for Predicting Nephropathy Secondary to Radiocontrast After a Percutaneous Coronary Intervention
- Strategy of Pannu et al for Managing a Patient with One or More Risk Factors for Contrast-Induced Nephropathy
- Nephrogenic Systemic Fibrosis (Nephrogenic Fibrosing Dermatopathy) Associated with the Use of Gadolinium-Based Contrast Agents
- Risk of Lung Cancer After Radon Exposure
- Definitions of Radioactive Misadventures Reportable to the Nuclear Regulatory Commission
- Exposure Limits for Ionizing Radiation
- Radiologic Examination in Women of Child-Bearing Age
- Contraindications to Magnetic Resonance Imaging (MRI)
- Excretion of Radionuclides in Breast Milk
- Safety Precautions for Patients Treated with I-131 Labeled Tositumomab
- Hazards Associated with the Magnetic Field Generated by a Magnetic Resonance Imaging Unit
- Managing a Patient with Claustrophobia or Anxiety Associated with a Magnetic Resonance Imaging (MRI) Unit
- MRI-Induced Skin Burns in Patient with Tattoos
- Triggering of Radiation Alarms Following the Use of a Radionuclide
- Cutaneous Burn Associated with a Metal-Backed Transdermal Patch in a Magnetic Resonance Imaging (MRI) Unit
- Radiation Recall Syndromes
- Using Thin Layer Chromatography to Determine the Radiochemical Purity of Technetium Tc99m Sestamibi (Cardiolite)
- Localization of Gastrointestinal Bleeding with Radionuclide-Tagged Erythrocyte Scintigraphy (Tagged Red Blood Cell Scan)
- Tagged Red Blood Cell Scintigraphy for Identifying a Non-Enteric Source of Bleeding
- Barium Embolism Following Barium Enema
- Colon Perforation During Barium Enema
- Postembolization Syndrome
- Postablation Syndrome
- Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) Following Radioembolization of a Liver Tumor
- Dosing Mesna as a Urothelial Protectant in a Patient Receiving Standard Dose Ifosfamide
- Dosing Amifostine (Ethyol) in a Patient Receiving Cancer Therapy
- Minimizing Hypotension During an Infusion of Amifostine
- Managing Hypotension During Infusion of Amifostine
- Dosing Dexrazoxane in a Patient Being Treated with Doxorubicin
- Dosing Dexrazoxane to Manage a Patient with Extravasation of Doxorubicin
- Discontinuation of Doxorubicin and Dexrazoxane for Myocardial Dysfunction
- Dosing Palifermin (Kepivance) to Reduce Oral Mucositis Associated with Hematopoietic Stem Cell Transplant (HSCT)
- Risk Factors for a Significant Radiation Exposure Associated with Depleted Uranium Munitions (DUM)
- Phases of Acute Polonium-210 Poisoning
- Risk Factors for Internal Contamination of a Healthcare Worker Caring for a Patient with Polonium-210 Poisoning
- Risk Factors of Ray-Coquard et al for Early Death Following Conventional Chemotherapy
- Nomogram of Hyman et al for Predicting Cycle One Serious Drug-Related Toxicity (SDRT) in a Phase I Oncology Trial
- Score of Wongso et al for Treatment-Related Mortality (TRM) in a Patient with Advanced Stage Hodgkin Disease
- Immune-Related Adverse Events (irAE) Associated with the anti-CTLA-4 Antibodies Ipilimumab and Tremelimumab
- Grading Criteria of Henson et al for Defecation Urgency Following Therapy for Pelvic Cancer
- Clinical Indicators of Caudell et al for Severe Long-Term Dysphagia Following Radiation Therapy for Head and Neck Cancer
- Risk Factors of Caudell et al for Severe Long-Term Dysphagia Following Radiation Therapy for Head and Neck Cancer
- Immune-Mediated Enterocolitis Associated with Targeted Therapy with Monoclonal anti-CTLA-4 Antibodies (Ipilimumab, Tremelimumab)
- Hypogonadism in a Male Patient Treated for Cancer
- Rib Fracture Following Stereotactic Body Radiotherapy (SBRT) for Non-Small Cell Lung Cancer
- Grading System for Rib Fracture Following Stereotactic Body Radiation Therapy (SBRT) for a Peripheral Lung Tumor
- Nomogram of Taremi et al for Predicting Radiotherapy-Induced Bone Injury (RIBI) Following Stereotactic Body Radiotherapy (SBRT) for a Lung Cancer
- Pain Flare Following External Beam Radiotherapy of Bone Metastases
- Model of Meanwell et al for Predicting Encephalopathy in a Patient Receiving Combination Chemotherapy with Ifosfamide and Mesna
- Risk Factors of Mueller et al for Stroke in Childhood Cancer Survivors Treated with Cranial and Cervical Radiation Therapy
- Risk Factors of Heckl et al for Radiation-Induced Cavernous Hemangioma of the Brain
- Causes of a Super Scan (Super Bone Scan)
- Uridine Administration for 5-Fluorouracil (5-FU) Toxicity
- Chemotherapy-Associated Steatohepatitis (CASH)
- Local Tissue Injury Associated with Extravasation of Iodinated Intravenous Contrast Material
- Post-Radiofrequency Ablation Syndrome (PRFAS)
- Nomogram of Pond et al for Predicting a Serious Adverse Event During Cycle One of a Phase II Clinical Trial for a Molecularly Targeted Agent
- Risk Factors of Khera et al for Nonmalignant Late Effects Following Hematopoietic Cell Transplant (HCT)
- Nonmalignant Late Effects of Khera et al Following Hematopoietic Cell Transplant (HCT)
- Criteria of Slama et al for Complete Atrioventricular Block Following Mediastinal Irradiation
- Intrarectal Instillation of Dilute Formalin to Control Hemorrhagic Proctitis
- Chutkan Scale for Hemorrhagic Radiation Proctitis
- Endoscopic Classification of Chi et al for Chronic Radiation-Induced Proctopathy (Rectal Telangiectasia Density, RTD)
- Grades of Rubbia-Brandt for Sinusoidal Dilatation in Chemotherapy-Associated Sinusoidal Dilatation
- Blue Liver Syndrome (BLS)
- Chemotherapy-Induced Splenic Enlargement and Perioperative Complications in Patients Undergoing Hepatic Resection of Metastatic Colorectal Cancer
- Risk Factors of Riachy et al for Hemorrhagic Cystitis in Pediatric Cancer Patients
- 1% Alum Irrigation to Control Hemorrhagic Cystitis and Aluminum Toxicity
- Intravesical Instillation of Dilute Formalin to Control Hemorrhagic Cystitis
- Hyperbaric Oxygen Therapy for Management of Radiation-Induced Hemorrhagic Cystitis
- Hypogonadism Associated with Crizotinib Therapy for Metastatic Adenocarcinoma of the Lung
- Barium Peritonitis
- Barium Appendicitis
- Barium Aspiration
- 30-Day Readmission Rate for Chemotherapy-Related Complications
- Immune-Related Adverse Events (irAE) Associated with the anti-PD-1 Antibodies
- Immune-Related Adverse Events (irAE) Associated with an Anti-Tumor Vaccine
- Risk Factors of Sakurada et al for Interstitial Lung Disease (ILD) Associated with Chemotherapy for Lung Cancer
- Autoimmune Pneumonitis Associated with anti-PD-1 Therapy
- Risk Factors of Armenian et al for Long-Term Pulmonary Function in a Patient Who Has Survived Childhood Cancer
- Tracheomediastinal Fistula (TMF) Following Therapy of an Intrathoracic Tumor
- Heart Dose Model of Chow et al for Predicting Risk of Congestive Heart Failure in a Childhood Cancer Survivor
- Carotid Blowout Syndrome (CBS)
- ABCDE Steps of Moslehi and Deininger for Preventing Cardiovascular Disease in a Patient Receiving a Tyrosin Kinase Inhibitor (TKI) for Chronic Myeloid Leukemia (CML)
- Cardiac Risk Score (CRS) of Romond et al for a Cardiac Event After Adjuvant Chemotherapy
- Patterns of Christianen et al for Long-Term Swallowing Dysfunction After Definitive Radiotherapy or Chemoradiation for Head and Neck Squamous Cell Carcinoma
- Total Dysphagia Risk Score (TDRS) of Langendijk et al
- Risk Factors of Schmeier et al for Pelvic Fracture After Radiation Therapy for Cervical Carcinoma
- Paclitaxel-Induced Peripheral Neuropathy
- Criteria of Black et al for Stroke-like Migraine Attacks after Radiation Therapy (SMART)
- Nomogram of Hu et al for Predicting the Risk of Chemotherapy-Induced Nausea and Vomiting (CINV) in a Cancer Patient
- Prognostic Factors of Han et al for a Cancer Patient Treated in a Phase 1 Clinical Trial
- Model of Hosmer et al for Predicting Febrile Neutropenia (FN) During the First Cycle of Chemotherapy for Cancer
- Risk Factors of Libourel et al for Arterial or Venous Thrombosis in a Patient with Acute Myeloid Leukemia (AML) Undergoing Induction Chemotherapy
- Risk Factors of Vera-Llonch et al for Oral Mucositis Associated with Radiation Therapy for a Head and Neck Cancer
- mTOR (Mammalian Target of Rapamycin) Inhibitor Associated Stomatitis (mIAS) Scale of Boers-Doets and Lalla
- Infarction of the Tongue (Lingual Infarction) Associated with Head and Neck Radiation Therapy
- Radiation Vasculopathy
- Models of Dranitsaris et al for Predicting Cardiotoxicity in a Woman with Breast Cancer Who Is Treated with Doxorubicin
- Prediction Score of Dranitsaris and Lacouture for Diarrhea in a Breast Cancer Patient Treated with Lapatinib and Capecitabine
- Differential Diagnosis of Radiation Anoproctitis
- Ovarian Function Score (OFS) of Li et al for a Premenopausal Women with Breast Cancer and Chemotherapy-Associated Amenorrhea
- Risk Factors of Kanbayashi et al for Hand-Foot Skin Reaction (HFSR) Associated with Sorafenib Therapy
- Prediction Score of Dranitsaris et al for Hand-Foot Skin Reaction (HFSR) in a Cancer Patient Treated with Sorafenib
- Prediction Score of Dranitsaris and Lacouture for a Skin Rash in a Breast Cancer Patient Treated with Lapatinib and Capecitabine
- Gemcitabine Associated Pseudocellulitis
- Risk Factors for Cytarabine Neurotoxicity
- Somnolence Syndrome (Hypersomnolence) Following Cranial Radiation Therapy
- Nuclear Reactor Meltdown
- Managing a Patient Exposed to a Nuclear Reactor Accident (Chernobyl. Other)
- Severity Score of Ma et al for an Overdose of 5-Fluorouracil (5-FU)
- Radiation-Associated Valvular Heart Disease
- ECG Changes Associated with Chemotherapy Using 5-Fluorouracil (5-FU) or Other Antimetabolites
- ECG Changes Associated with Chemotherapy Using a Taxane
- ECG Changes Associated with Chemotherapy Using Tyrosine Kinase Inhibitors (TKI)
- Risk Factors of Nguyen et al for Breast-Cancer Related Lymphedema (BCRL) of the Upper Extremity
- Risk Factors of Kim et al for Sacral Fracture Complicating Chemoradiation for Rectal Carcinoma
- International Nuclear and Radiological Event (INES) Scale
- Risk Factors of Brooks et al for Chemotherapy-Related Hospitalizationin a Patient Receiving Palliative Chemotherapy
- Nijmegen Nursing Mucositis Scoring System (NNMSS) of Potting et al for Oral Mucositis in Cancer Patients
- MacDibbs Mouth Assessment Tool of Dibble et al for Evaluating Oral Mucositis in a Patient Receiving Radiation Therapy
- Impact of Radiation Dose on a Pacemaker or Implantable Cardioverter Defibrillator (ICD) Based on the Study of Hurkmans et al
- Clinical Triggers for a Dysphagia Exam in a Patient Treated for Head and Neck Cancer
- Predictive Enteral Grading (PEG) Score of Poulsen et al for Acute Grade 4 Swallowing Toxicity Following Radiotherapy Alone for Stage III or IV Squamous Cell Carcinoma of the Head and Neck
- Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Physician-Rate Swallowing Dysfunction at 6 Months After Therapy
- Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Problems Swallowing Liquids
- Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Problems Swallowing Soft Foods
- Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Problems Swallowing Solid Food
- Models of Christianen et al for Swallowing Dysfunction After Chemoradiation for Head and Neck Cancer: Problems Choking When Swallowing
- Classification of Dische for Swallowing Toxicity After Radiation Therapy for Head and Neck Cancer
- Risk Factors of Languis et al for Weight Loss and Malnutrition in a Patient Treated for Early Stage Laryngeal Cancer
- Criteria of the AAPT for Chemotherapy-Induced Peripheral Neuropathy (CIPN)
- Dirty Bomb (Radiological Dispersal Explosive)
- Criteria of Ferrara et al for a Patient Being Unfit for Intensive Chemotherapy for Acute Myeloid Leukemia
- Criteria of Ferrara et al for a Patient Being Unfit for Nonintensive Chemotherapy for Acute Myeloid Leukemia
- On Target, Off Tumor Toxicity Associated with CAR T-Cell (CART) Therapy
- Acute Toxicities of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- Laboratory Findings of Uhl et al Predictive of Bleeding Associated with Cancer Therapy
- Immune Checkpoint Inhibitor-Associated Cardiac Disease
- Radiation-Associated Stenosis of the Carotid Artery
- Radiation-Induced Heart Disease
- Nilotinib Vasculopathy with Occlusive Atherosclerotic Disease
- Model of Delobel et al for Rectal Toxicity Following Radiotherapy for Prostate Cancer
- Hepatotoxicity Associated with Arsenic Trioxide Chemotherapy
- Hepatotoxicity Associated with Cancer Therapy
- Model of Motwani et al for Acute Kidney Injury (AKI) After the First Course of Cisplatin (C-AKI Score)
- Post-Irradiation Lichen Sclerosus et Atrophicus
- Risk Factors of Yamamoto et al for Severe Lymphosclerosis in the Lower Extremity Secondary to Cancer Therapy
- Post-Chemotherapy Arthralgia or Arthritis (Chemotherapy-Associated Arthropathy)
- CARTOX10 Score of Neelapu et al
- CAR T-Cell-Related Encephalopathy Syndrome(CRES) Grading System of Neelapu et al
- Endocrinopathies Associated with Immune Checkpoint Inhibitor Therapy
- Risk Factors of Kaya et al for Contrast-Induced Nephropathy in a Patient Undergoing a Primary Percutaneous Coronary Intervention (PCI)
- Contrast Volume to Estimated GFR Ratio for Prediction of Contrast-Induced Acute Kidney Injury
- Risk Score of Fu et al for Contrast-Induced Nephropathy in an Elderly Patient Undergoing Percutaneous Coronary Intervention (PCI)
- Risk Score of Gao et al for Contrast-Induced Nephropathy (CIN) After Cardiac Catheterization in Chinese Patients
- Grades of Harjai et al for Contrast Nephropathy
- Nomogram of Zhou et al for Predicting Contrast-Induced Acute Kidney Injury in a Patient with an Acute Myocardial Infarction Treated Invasively
- Somatic Effects of Exposure to Atomic Radiation
- Factors Associated with a Chronic Lymphocytic Leukemia (CLL) Patient Being Unfit for Chemotherapy
- Cytarabine (ara-C) Syndrome
- Dynamic Imaging Grade of Swallowing Toxicity (DIGEST)
- Risk Factors of Abayomi for Cognitive Decline After Radiation Therapy for a Head and Neck Cancer
- Scale for Chemotherapy-Induced Long-Term Neurotoxicity (SCIN) of Oldenburg et al
- Neutrophil-to-Lymphocyte Ratio (NLR) and Other Risk Factors of Kaya et al for Contrast-Induced Nephropathy Following Primary Percutaneous Coronary Intervention (PCI)
- Recommendations of Andersen to Avoid Radiocontrast Material Associated Renal Injury in a Patient with Chronic Kidney Disease
- Immunotherapy-Associated Tumor Hyperprogression
- Tumor Pseudoprogression Following Cancer Therapy
- Tumor Pseudoresponse Following Cancer Therapy
- PROACCT Score of Grant et al to Predict Acute Care After the Initiation of Systemic Cancer Therapy
- Revised WCCNR Stomatitis Staging System for Chemotherapy-Induced Stomatitis
- Interstitial Lung Disease Associated with Imatinib Therapy
- Criteria of Sachak et al for Neutropenic Entercolitis
- Xerosis (Dry Skin) Associated with Targeted Therapy
- Model of Cella et al for Radiation-Induced Hypothyroidism
- Reducing the Intensity of Chemotherapy in a Frail Adult
- Prognostic Model of Ahn et al for Chemotherapy-Induced Febrile Neutropenia
- Dental Changes Associated with Radiation Therapy for a Head and Neck Cancer
- Immune-Related Pneumonitis Associated with Immune Checkpoint Inhibitors
- Aortic Stenosis Following Mediastinal or Chest Radiation
- Radiation Cardiomyopathy
- Radiation Pericarditis
- Risk Factors of Darby et al for Radiation-Associated Ischemic Heart Disease in a Woman Treated for Breast Cancer
- Risk Factors of Miften et al for Radiotherapy Affecting an Implanted Cardiac Pacemaker (ICP) and Cardioverter-Defibrillator (ICD)
- Aortitis Associated with Oncologic Drug Therapy
- Hepatotoxicity Associated with Immune Checkpoint Inhibitors (ICI)
- Clinical Features of McMahon et al for Acute Kidney Injury (AKI) in Children Following Cisplatin Therapy
- Skin Toxicity Associated with Immune Checkpoint Inhibitors
- Radiation-Induced Alopecia
- Arthralgias or Inflammatory Arthritis Associated with Immune Checkpoint Inhibitor (ICI) Therapy
- Model of Rubin et al for Predicting Neurotoxicity After Chimeric Antigen Receptor T-Cell (CART) Therapy
- Patients at Risk for Developing Cataracts After Exposure to Nonionizing Radiation
- Radiation-Induced Malignant Glioma Following Gamma Knife Radiosurgery for an Intracranial Arteriovenous Malformation (AVM)
- Risk Factors of Lam et al for Acute Myeloid Leukemia (AML) Arising in a Survivor of Non-Hodgkin's lymphoma (NHL)
- Risk Models of Tsai et al for Acute Kidney Injury Following Percutaneous Coronary Intervention (PCI): Model for Acute Kidney Injury (AKI)
- Risk Models of Tsai et al for Acute Kidney Injury Following Percutaneous Coronary Intervention (PCI): Model for Acute Kidney Injury (AKI) Requiring Dialysis
- Score of Brown et al for Predicting Serious Contrast-Related Renal Dysfunction After Percutaneous Coronary Intervention
- Factors Impacting the Definition of Dose-Limiting Toxicity (DLT) for a Chemotherapeutic Agent
- Abscopal Effect
- Model of Li et al for Predicting Nasopharyngeal Necrosis Following Radiation Therapy of a Nasopharyngeal Carcinoma
- Exceptional Responder to Cancer Therapy
- Predictors of Moth et al for Severe Chemotherapy-Related Toxicity in an Older Adult
- Risk Factors of Jagsi et al for Acute Toxicity Following Breast Radiotherapy
- Excessive Myelosuppression Following Chemoradiation in Patients with Fanconi Anemia
- Nomogram of Wang et al for Predicting Radiation Pneumonitis Following Radiation Therapy of Esophageal Cancer
- Nomogram of Xu et al for Predicting Radiotherapy-Related Esophageal Fistula in a Patient with Esophageal Cancer
- Nomogram of Gross et al for Predicting Lymphedema in a Woman Following Axillary Surgery and Radiation Therapy for Breast Cancer
- Risk Factors of Park et al for Pelvic Insufficiency Fracture in a Woman with Cervical Cancer
- Model of Wang et al Predicting Temporal Necrosis in a Patient with Nasopharyngeal Carcinoma Following Intensity Modulated Radiation Therapy
- Model of Huang et al for Predicting Symptomatic Epilepsy in a Patient with Radiation-Induced Brain Necrosis
- Autoimmune Keratitis Associated with Atexolizumab Therapy
- Model of Theunissen et al for Hearing Loss Following Cisplatin Chemoradiotherapy for Head and Neck Cancer
- Tamoxifen Retinopathy
- Complications of Intra-Arterial Chemotherapy (IAC) for Retinoblastoma
- Type 1 Diabetes Mellitus Associated with Pembrolizumab Therapy
- Predictive Model of Wu et al for Imminent Death for a Patient Receiving Palliative Radiotherapy
- TEACHH Model for Predicting Life Expectancy of a Patient with Metastatic Cancer Receiving Palliative Radiotherapy
- NEAT Predictive Model of Kao et al for Survival of a Patient Receiving Palliative Radiotherapy
- CAR T-Cell Persistent Cytopenias
- Granulomatosis with Polyangiitis (GPA, Wegener's Granulomatosis) Associated with Immune Checkpoint Inhibitor Therapy
- Nomogram of Feng et al for Predicting Carotid Blowout Syndrome in a Patient with a Head and Neck Cancer
- Risk Factors for Fat Necrosis Following Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer
- Classification of Garsa et al for Fat Necrosis Following Radiation Therapy for Breast Cancer
- Classification of Poti et al for Fat Necrosis Following Breast Irradiation
- Maculopathy Associated with a Blood-Brain Barrier Disruption (BBBD) Chemotherapy Regimen
- Tearing After Chemotherapy
- Risk Factors of Demoor-Goldschmidt et al for Small Adult Height in a Childhood Cancer Survivor
- Tool of Magnuson et al for Predicting Severe Toxicity in an Older Patient Following Chemotherapy for Early-Stage Breast Cancer
- Risk Factors for Hemorrhage in a Patient Treated with Ibrutinib
- Models of Li et al for Oral Mucositis During Chemo-Radiotherapy of Nasopharyngeal Carcinoma: Model Using Mucosal Surface Contour (MSC)
- Models of Li et al for Oral Mucositis During Chemo-Radiotherapy of Nasopharyngeal Carcinoma: Model Using Oral Cavity Contour (OCC)
- World Health Organization (WHO) Oral Mucositis Scale
- International Society of Pediatric Oncology Boston Ototoxicity Scale of Brock et al
- Model of Baek et al for Progression of Postcontrast Acute Kidney Injury in a Chronic Kidney Disease Patient
- Immune Hemolytic Anemia Associated with Contrast Media
- Risk Factors for Complications Following Use of Radiocontrast Material in a Patient with Sickle Cell Anemia
- Thrombocytopenia Associated with Infusion of a Radiocontrast Medium
- ASCO Review of Immune Checkpoint Inhibitor Complications: Infusion-Related Reaction
- ASCO Review of Immune Checkpoint Inhibitor Complications: Aplastic Anemia
- ASCO Review of Immune Checkpoint Inhibitor Complications: Hemolytic Anemia
- ASCO Review of Immune Checkpoint Inhibitor Complications: Lymphopenia
- ASCO Review of Immune Checkpoint Inhibitor Complications: Immune Thrombocytopenia Purpura (ITP)
- ASCO Review of Immune Checkpoint Inhibitor Complications: TTP and HUS
- ASCO Review of Immune Checkpoint Inhibitor Complications: Venous Thromboembolism
- ASCO Review of Immune Checkpoint Inhibitor Complications: Acquired Hemophilia A
- ASCO Review of Immune Checkpoint Inhibitor Complications: Pneumonitis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Cardiovascular Toxicity
- CHACS-CV (Childhood & Adolescence Cancer Survivor Cardiovascular) Risk Score of Oikonomou et al
- ASCO Review of Immune Checkpoint Inhibitor Complications: Colitis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Hepatitis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Renal Toxicities
- ASCO Review of Immune Checkpoint Inhibitor Complications: Bullous Skin Disease
- ASCO Review of Immune Checkpoint Inhibitor Complications: Skin Rash
- ASCO Review of Immune Checkpoint Inhibitor Complications: Severe Cutaneous Adverse Reaction (SCAR)
- ASCO Review of Immune Checkpoint Inhibitor Complications: Inflammatory Arthritis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Myositis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Polymyalgia
- ASCO Review of Immune Checkpoint Inhibitor Complications: Aseptic Meningitis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Autonomic Neuropathy
- ASCO Review of Immune Checkpoint Inhibitor Complications: Demyelinating Disease
- ASCO Review of Immune Checkpoint Inhibitor Complications: Encephalitis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Guillain-Barre Syndrome
- ASCO Review of Immune Checkpoint Inhibitor Complications: Peripheral Neuropathy
- ASCO Review of Immune Checkpoint Inhibitor Complications: Episcleritis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Uveitis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Adrenal Insufficiency
- ASCO Review of Immune Checkpoint Inhibitor Complications: Diabetes Mellitus
- ASCO Review of Immune Checkpoint Inhibitor Complications: Pituitary Toxicity and Hypophysitis
- ASCO Review of Immune Checkpoint Inhibitor Complications: Primary Hypothyroidism
- ASCO Review of Immune Checkpoint Inhibitor Complications: Thyrotoxicosis
- Oncology Acute Care Risk Prediction Model of Csik et al (REDUCE Score)
- Chemotherapy Toxicity Risk Score (CTRS)
- Predictors of Wu et al for Imminent Death of a Cancer Patient Being Evaluated for Palliative Radiotherapy
- Model of Zhu et al for Predicting Neutropenia After Etoposide-Based Chemotherapy
- SAVED Score of Li et al for Immunomodulatory Drug-Associated Thrombosis
- FENCE Score of Aagaard et al for Predicting Febrile Neutropenia After Cancer Chemotherapy
- Model of Venalainen et al for Predicting Chemotherapy-Induced Neutropenia
- CSR-FENCE Score of Aagaard et al for Predicting Febrile Neutropenia During Chemotherapy Cycles 2 to 6
- Thoracic Air Leak Syndrome (TALS)
- Risk Factors of Said et al for Bullous Pemphigoid Following Immune Checkpoint Inhibitor Therapy
- MEK Inhibitor-Associated Retinopathy (MEKAR)
- Risk Factors of Keilty et al for Hearing Loss After Chemoradiation for Head and Neck or Brain Tumors in Children
- Grading System of Chang and Chinosornvatana for Cisplatin Ototoxicity in Children
- Nomogram of Keilty et al for Hearing Loss Following Chemoradiation for a Pediatric CNS or Head and Neck Tumor
- Score of van der Velden et al for Predicting Pain Response to Palliative Radiation for Bone Metastases
- Impact of Parenteral Iron on Magnetic Resonance Imaging (MRI)
- Histologic Grading of Radiation Effect
- Score of Sasaki et al for Predicting Survival of Intensive Chemotherapy in Acute Myeloid Leukemia (AML)
- Radiation Fibrosis Syndrome (RFS)
- Risk Factors for the Radiation Fibrosis Syndrome (RFS)
- Toxicity of Radiation Therapy for Gynecologic Malignancy: Acute Toxicity
- Toxicity of Radiation Therapy for Gynecologic Malignancy: Chronic Toxicity
- Risk Factors of Moik et al for Arterial and Venous Thromboemboli in a Cancer Patient Receiving an Immune Checkpoint Inhibitor
- STRIPE Algorithm of Palma et al for Radiation Pneumonitis in a Patient with Lung Cancer
- Complications of Komori et al Following Radiation Therapy of Advanced Rectal Cancer
- Post-Radiation Urethral Stricture
- Risk Factors for Premature Ovarian Failure in a Woman Treated with Cyclophosphamide (Cytoxan)
- Models of Rattay et al for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort: Model for Acute Erythema
- Models of Rattay et al for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort: Model for Acute Desquamation
- Predictors of LeBrun et al for Wound Complications Following Radiation Therapy and Surgical Resection of a Soft Tissue Sarcoma
- Score of Abuhelwa et al for Predicting Hand-Foot Syndrome in a Patient Treated with Sorafenib
- Risk Factors of Jarvers et al for Wound Complications Following Surgical Stabilization of Spinal Metastases
- Chemotherapy-Induced Osteonecrosis
- Radiation-Induced Cranial Neuropathy
- Models of Fujiwara et al for Predicting Contrast-Associated Acute Kidney Injury (CA-AKI) After Percutaneous Coronary Intervention (PCI): Simple Score
- Models of Fujiwara et al for Predicting Contrast-Associated Acute Kidney Injury (CA-AKI) After Percutaneous Coronary Intervention (PCI): Logistic Regression Model
- Risk Score of Yang et al for Predicting Unplanned Renal Replacement Therapy (RRT) After Coronary Catheterization
- Radiation Recall Pneumonitis (RRP)
- Radiation Recall Dermatitis (RRD)
- Risk Factors for Failure of Radioiodine Therapy for Graves' Disease